Changes to the Revolving Door: Trump’s Ethics Executive Order
Client Alert | less than 1 min read | 01.30.17
On January 28, 2017, President Trump issued an executive order setting forth the ethics restrictions for its executive agency appointees. These restrictions, discussed more fully in our blog post, are simultaneously more restrictive and less restrictive than their 2009 Obama counterparts, and appear to be more focused on appointees’ conduct following their exit from Government rather than on their conduct preceding and during their appointments.
Contacts
Partner
She/Her/Hers
Insights
Client Alert | 2 min read | 05.09.25
FDA Seeks Stakeholder Consultation on Prescription Drug User Fee Reauthorization
On May 8, the U.S. Food and Drug Administration (FDA) took steps to begin the process for reauthorizing the Prescription Drug User Fee Amendments (PDUFA) by announcing a public meeting to be held on July 14, 2025. The agency invited public stakeholders, including patient and consumer advocate groups, health care professionals, and scientific and academic experts to participate in the meeting and subsequent public meetings to consult on the PDUFA reauthorization.
Client Alert | 2 min read | 05.09.25
New SF-328 for Foreign Ownership, Control, and Influence Assessments Approved, Publication Imminent
Client Alert | 4 min read | 05.08.25
Client Alert | 4 min read | 05.07.25
